One of The Ocean’s Deadliest Snails Gave Us a Nonaddictive Painkiller and Scientists Say They Have Barely Scratched The Surface
The venom of the geography cone snail (*Conus geographus*), one of the ocean’s deadliest creatures, contains over 1,000 unique peptides that researchers are studying for medical applications, including nonaddictive painkillers. Scientists have already developed ziconotide, an FDA-approved drug derived from the magician cone snail (*Conus magus*), for treating severe chronic pain without opioid risks, and they believe the potential of conotoxins remains largely untapped.
The geography cone snail (*Conus geographus*), known for its intricate shell and deadly venom, is a prime focus of medical research due to its complex venom system. While its sting can cause paralysis and death in humans, the same venom contains over 1,000 peptides, offering a vast library of potential drug candidates across the roughly 800 known cone snail species. Researchers like Mandë Holford, a Harvard University venom expert, highlight the paradox: what kills can also cure. Cone snails, found in tropical and subtropical oceans worldwide, hunt using a harpoon-like tooth to inject venom composed of conotoxins—compounds targeting specific parts of the nervous system. The geography cone snail, nicknamed the 'cigarette snail' due to a myth about victims having time to smoke before paralysis, poses real risks, including respiratory failure from severe envenomation. The precision of conotoxins makes them attractive for drug development, as they can selectively disable pain pathways without the side effects of opioids. Ziconotide, derived from the magician cone snail (*Conus magus*), was approved by the U.S. FDA in 2004 for treating severe chronic pain resistant to conventional treatments. Unlike opioids, ziconotide does not act on opioid receptors, eliminating addiction risks. Scientists estimate they have barely scratched the surface of conotoxins’ potential, with the vast diversity of cone snail species offering untapped possibilities. The venom’s ability to target specific receptors and ion channels with high accuracy could lead to breakthroughs in pain management and other medical fields.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.